TEVIMBRA
NDC 72579-125, tislelizumab-jsgr, injection, solution, concentrate, from BeOne Medicines USA, Inc..
- Product NDC
- 72579-125
- Status
- Listed
- Labeler
- BeOne Medicines USA, Inc.
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761232
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72579-125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TISLELIZUMAB10 mg/mL
Pharmacologic classes
Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72579-125-00 | 72579012500 | 1 VIAL, GLASS in 1 CARTON (72579-125-00) / 15 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/08ef1e3e-496f-4b0b-94ee-fbba3cc1985a
Use it
Look up 72579-125 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72579-125 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72579-125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.